Structural comparison of endomorphin-2 and its conformationally restricted analog
Tóm tắt
In the present study, the effect of a conformational constraint introduced into the endomorphin-2 (Tyr-Pro-Phe-Phe-NH2, EM-2) structure was studied using computational analysis and radioligand binding assay. EM-2 was modified by connecting nitrogen atoms of both phenylalanine residues by a methylene bridge. The obtained analog did not bind to the µ- or δ-opioid receptors in the in vitro studies. The computational analysis of this analog showed twisted, type IV turns and the absence of canonical β-turns typical for the EM-2 structure, which can be explained by the lack of hydrogen bonds involving Phe4. Our results show that the introduction of chemical constraint in the EM-2 structure has a significant effect on opioid receptor affinity and in vitro bioactivity.
Tài liệu tham khảo
J.E. Zadina, L. Hackler, L.J. Ge, A.J. Kastin, Nature 386, 499 (1997)
G. Horváth, Pharmacol. Ther. 88, 437 (2000)
A. Janecka, R. Staniszewska, K. Gach, J. Fichna, Peptides 29, 2066 (2008)
C. Tomboly, A. Peter, G. Toth, Peptides 23, 1573 (2002)
C. Sakurada, S. Sakurada, T. Hayashi, S. Katsuyama, K. Tan-No, T. Sakurada, Biochem. Pharmacol. 66, 653 (2003)
A.J. Kastin, M.B. Fasold, R.R. Smith, K.A. Horner, J.E. Zadina, Exp. Brain Res. 139, 70 (2001)
Y. Koda, K. Shiotani, I. Toth, Y. Tsuda, Y. Okada, J.T. Blanchfield, Bioorg. Med. Chem. Lett. 17, 2043 (2007)
T. Yamazaki, S. Ro, M. Goodman, N.N. Chung, P.W. Schiller, J. Med. Chem. 36, 708 (1993)
M.G. Paterlini, F. Avitabile, B.G. Ostrowski, D.M. Ferguson, P.S. Portoghese, Biophys. J. 78, 590 (2000)
I. Lengyel, G. Orosz, D. Biyashev, L. Kocsis, M. Al-Khrasani, A. Ronai, C. Tomboly, Z. Furst, G. Toth, A. Borsodi, Biochem. Biophys. Res. Commun. 290, 153 (2002)
V.J. Hruby, R.S. Agnes, Biopolymers 51, 391 (1999)
Y. Okada, A. Fukumizu, M. Takahashi, Y. Shimizu, Y. Tsuda, T. Yokoi, S. D. Bryant, L. H. Lazarus, Biochem. Biophys. Res. Commun. 276, 7 (2000)
P.W. Schiller, T.M. Nguyen, G. Weltrowska, B.C. Wilkes, B. J. Marsden, C. Lemieux, N.N. Chung, Proc. Natl. Acad. Sci. U.S.A 89, 11871 (1992)
R. Dharanipragada, K. Van Hulle, A. Bannister, S. Bear, L. Kennedy, V.J. Hruby, Tetrahedron 48, 4733 (1992)
E. Nicolas, K.C. Russell, J. Knollenberg, V.J. Hruby, J. Org. Chem. 58, 7565 (1993)
L.W. Boteju, K. Wegner, X. Qian, V.J. Hruby, Tetrahedron 50, 2391 (1994)
V.J. Hruby, G. Toth, C.A. Gehrig, L.F. Kao, R. Knapp, G.K. Lui, H. Yamamura, T.H. Kramer, P. Davis, T.F. Burks, J. Med. Chem. 34, 1823 (1991)
M. Keller, C. Boissard, L. Patiny, N. N. Chung, C. Lemieux, M. Mutter, P. W. Schiller, J. Med. Chem. 44, 3896, (2001)
C. Tomboly, K.E. Kover, A. Peter, D. Tourwe, D. Biyashev, S. Benyhe, A. Borsodi, M. Al-Khrasani, A.Z. Ronai, G. Toth, J. Med. Chem. 47, 735 (2004)
Y. Yu, X. Shao, Y. Cui, H.M. Liu, C.L. Wang, Y.Z. Fan, J. Liu, S.L. Dong, Y.X. Cui, R. Wang, Chem. Med. Chem. 2, 309 (2007)
Y. Yu, X. Shao, C.L. Wang, H.M. Liu, Y. Cui, Y.Z. Fan, J. Liu, R. Wang, Peptides 28, 859 (2007)
Y. In, K. Minoura, K. Tomoo, Y. Sasaki, L.H. Lazarus, Y. Okada, T. Ishida, FEBS J. 272, 5079 (2005)
W.M. Kazmierski, R.D. Ferguson, A.W. Lipkowski, V.J. Hruby, Int. J. Pept. Protein Res. 46, 265 (1995)
A. Borics, G. Toth, J. Mol. Graph. Model. 28, 495 (2010)
Y. Tong, Y. M. Fobian, M. Wu, N.D. Boyd, K.D. Moeller, J. Org. Chem. 65, 2484 (2000)
J. Fichna, J.C. do-Rego, N.N. Chung, C. Lemieux, P.W. Schiller, J. Poels, J.V. Broeck, J. Costentin, A. Janecka, J. Med. Chem. 50, 512 (2007)
B. Lammek, M. Czaja, I. Derdowska, E. Lempicka, P. Sikora, W. Szkrobka, H.J. Trzeciak, J. Pept. Res. 51, 149 (1998)
J. Fichna, J.C. do-Rego, P. Kosson, J. Costentin, A. Janecka, Biochem. Pharmacol. 69, 179 (2005)
J. Wang, P. Cieplak, P.A. Kollman, J. Comp. Chem. 21, 1049 (2000)
J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, D.A. Case, J. Comput. Chem. 25, 1157 (2004)
S. Lovas, R.F. Murphy, In: Irvine, Williams (Eds.), Methods of Molecular Biology Neuropeptide Protocols (Humana Press, Totowa, NJ, 1997) Vol. 73, 209
W.C. Still, A. Tempczyk, R.C. Hawley, T. Hendrickson, J. Am. Chem. Soc. 112, 6127 (1990)
W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, M.L. Klein, J. Chem. Phys. 79, 926 (1983)
E. Lindahl, B. Hess, D. van der Spoel, J. Mol. Mod. 7, 306 (2001)
J.B. Ball, R.A. Hughes, P.F. Alewood, P.R. Andrews, Tetrahedron 49, 3467 (1993)
D. Frishman, P. Argos, Proteins 23, 566 (1995)
X. Daura, K. Gademann, B. Jaun, D. Seebach, W.F. van Gunsteren, A.E. Mark, Angew. Chem. Int. Ed. 38, 236 (1999)
T.G. Metzger, M.G. Paterlini, P.S. Portoghese, D.M. Ferguson, Neurochem. Res. 21, 1287 (1996)
M. Eguchi, R.Y. Shen, J.P. Shea, M. Lee, M. Kahn, J. Med. Chem. 45, 1395 (2002)
C. Tomboly, S. Ballet, D. Feytens, K.E. Kover, A. Borics, S. Lovas, M. Al-Khrasani, Z. Furst, G. Toth, S. Benyhe, D. Tourwe, J. Med. Chem. 51, 173 (2008)
R. Kruszynski, J. Fichna, J.C. do-Rego, T. Janecki, P. Kosson, W. Pakulska, J. Costentin, A. Janecka, Bioorg. Med. Chem. 13, 6713 (2005)
H.W. Kosterlitz, J.A. Lord, S.J. Paterson, A.A. Waterfield, Br. J. Pharmacol. 68, 333 (1980)
K.J. Chang, E.T. Wei, A. Killian, J.K. Chang, J. Pharmacol. Exp. Ther. 227, 403 (1983)